Basil Al-Sabeq

Basil Al-Sabeq practices at Methodist University Hospital in Memphis, Tennessee, part of Methodist Le Bonheur Healthcare.

Basil Al-Sabeq's NPI, 1821575069, was assigned on July 20, 2018. Basil Al-Sabeq graduated from University of Alberta in 2012. Basil Al-Sabeq holds Tennessee license 60571.

Basil Al-Sabeq's primary practice is Methodist University Hospital, at 1265 Union Ave Suite 700, Memphis, TN 38104 in Shelby County. The practice phone is (901) 516-8274.

Basil Al-Sabeq's primary practice is Methodist University Hospital in Memphis, Tennessee, part of Methodist Le Bonheur Healthcare. Basil Al-Sabeq is also affiliated with Methodist Olive Branch Hospital. The medical group on file is Sutherland Cardiology Clinic - Wolf River. Dmand AI also links Basil Al-Sabeq to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Basil Al-Sabeq practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Basil Al-Sabeq's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Basil Al-Sabeq is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Basil Al-Sabeq's licenses on file in 2 states: Tennessee and Arkansas.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT), heart failure and high cholesterol among the conditions Basil Al-Sabeq treats.

CMS data shows 1,059 Medicare services from Basil Al-Sabeq across 13 procedure codes in 2024, for 653 Medicare patients. Medicare paid $38,206 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 653 Medicare patients who saw Basil Al-Sabeq in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Basil Al-Sabeq's median patient age at 68, with 51% women.

In 2024, Basil Al-Sabeq wrote 901 Medicare Part D claims for 150 patients. 84% of them were for generic drugs. CMS names the drug for 834 of them, across 22 drugs with 11 or more claims each, at $158,446 in total drug cost. In 2023, CMS named 642 claims across 18 drugs.

Basil Al-Sabeq accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Basil Al-Sabeq, published from 2014 to 2020. The most frequent topics are Magnetic Resonance Imaging, Predictive Value of Tests and Echocardiography. Basil Al-Sabeq has published most often in Methodist Debakey Cardiovasc J. Basil Al-Sabeq's most frequent co-authors are Faisal Nabi, MD, Mohammed Chamsi-Pasha, MD and Dipan Shah, MD.

CMS Open Payments shows 61 general payments to Basil Al-Sabeq from 18 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 50% of the total. Abbott Laboratories paid the most, $2,035.

Basil Al-Sabeq graduated from University of Alberta in 2012.